Evidence map›Paper›PMID 21507922›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2011

Duffy-null-associated low neutrophil counts influence HIV-1 susceptibility in high-risk South African black women.

Veron Ramsuran, Hemant Kulkarni, Weijing He, Koleka Mlisana, Edwina J Wright, Lise Werner, John Castiblanco, Rahul Dhanda, Tuan Le, Matthew J Dolan and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 76 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Mucosal Immunity and HIV Acquisition in Women.Current opinion in physiology · 2021
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Benign ethnic neutropenia.Blood reviews · 2019
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 4 countries.

Veron RamsuranHIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Hemant Kulkarni
Weijing He
Koleka Mlisana
Edwina J Wright
Lise Werner
John Castiblanco
Rahul Dhanda
Tuan Le
Matthew J Dolan
Weihua Guan
Robin A Weiss
Robert A Clark
Salim S Abdool Karim
Sunil K Ahuja
Thumbi Ndung'u
The University of Texas Health Science Center at San Antonio · USCentre for the AIDS Programme of Research in South Africa · ZABurnet Institute · AUHenry M. Jackson Foundation · USUniversity College London · GBUniversity of Minnesota · US

Funding

The Viral Set Point in HIV-1 Subtype C InfectionU19AI051794 · NIAID · UNIVERSITY OF KWAZULU-NATAL · PI ABDOOL KARIM, SALIM S · 2002 to 2007
$22.5M
Host Genetic Determinants of HIV PathogenesisR37AI046326 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI AHUJA, SUNIL K · 2005 to 2014
$7.8M
Medical Research Council G0801176Medical Research Council G8712499NIAID NIH HHS R37 AI046326NIAID NIH HHS U19 AI051794NIAID NIH HHS U19 AI 51794PHS HHS R37046326PHS HHS TWO-0023
6 · The paper itself

Abstract

backgroundThe Duffy-null trait and ethnic netropenia are both highly prevalent in Africa. The influence of pre-seroconversion levels of peripheral blood cell counts (PBCs) on the risk of acquiring human immunodeficiency virus (HIV)-1 infection among Africans is unknown.

methodsThe triangular relationship among pre-seroconversion PBC counts, host genotypes, and risk of HIV acquisition was determined in a prospective cohort of black South African high-risk female sex workers. Twenty-seven women had seroconversion during follow-up, and 115 remained HIV negative for 2 years, despite engaging in high-risk activity.

resultsPre-seroconversion neutrophil counts in women who subsequently had seroconversion were significantly lower, whereas platelet counts were higher, compared with those who remained HIV negative. Comprising 27% of the cohort, subjects with pre-seroconversion neutrophil counts of <2500 cells/mm(3) had a ∼3-fold greater risk of acquiring HIV infection. In a genome-wide association analyses, an African-specific polymorphism (rs2814778) in the promoter of Duffy Antigen Receptor for Chemokines (DARC -46T > C) was significantly associated with neutrophil counts (P = 7.9 × 10(-11)). DARC -46C/C results in loss of DARC expression on erthyrocytes (Duffy-null) and resistance to Plasmodium vivax malaria, and in our cohort, only subjects with this genotype had pre-seroconversion neutrophil counts of <2500 cells/mm(3). The risk of acquiring HIV infection was ∼3-fold greater in those with the trait of Duffy-null-associated low neutrophil counts, compared with all other study participants.

conclusionsPre-seroconversion neutrophil and platelet counts influence risk of HIV infection. The trait of Duffy-null-associated low neutrophil counts influences HIV susceptibility. Because of the high prevalence of this trait among persons of African ancestry, it may contribute to the dynamics of the HIV epidemic in Africa.

Indexed as

Genetic Predisposition to DiseasePolymorphism, GeneticCohort StudiesDuffy Blood-Group SystemFemaleHIVHIV-1HumansMolecular Sequence DataNeutropeniaPromoter Regions, GeneticProspective StudiesReceptors, Cell SurfaceSequence Analysis, DNASouth AfricaACKR1 protein, humanDuffy Blood-Group SystemReceptors, Cell Surface

Identifiers

PMID21507922
PMCPMC3115278
OpenAlexW2113161108

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.